MOSCOW (Reuters) -A Russian Soyuz MS-28 spacecraft with two Russian cosmonauts and one NASA astronaut on board successfully docked with the International Space Station on Thursday, Russian space agency Roscosmos said.
But the agency later reported that the launch pad at the Baikonur Cosmodrome in Kazakhstan had sustained damage from the launch. It said the damage would be quickly repaired.
The Soyuz 2.1a rocket lifted off from the Baikonur Cosmodrome at 12:28 p.m. Moscow time (0928 GMT).
Late on Thursday, Russian news agencies quoted Roscosmos as saying the launch had taken place without incident, but damage was observed after an inspection of the launch area.
"Damage to a number of elements of the launch pad was detected. An assessment of the state of the launch complex is being conducted now," the agencies quoted Roscosmos as saying.
"All the necessary reserve elements are there to restore it and the damage will be eliminated very soon."
It said the crew was on board the station and in good health.
(Reporting by Anastasia Lyrchikova; Writing by Marina Bobrova; Editing by Andrew Osborn, Ron Popeski and Bill Berkrot)
LATEST POSTS
- 1
Find Unexpected, yet invaluable treasure Excursion Rentals - 2UN estimates over 2,000 Sudanese pregnant women have fled el-Fasher to escape conflict
- 3Vote in favor of Your Fantasy Vehicle: Which Notable Model Catches Your Heart?
- 4Self-sacrificing ants highlight the unity of their colony, say researchers
- 5How to track NASA’s Artemis II and Orion’s journey to the moon
- The Hybrid Volkswagen ID. ERA 9X Will Become the Brand’s New Flagship in China
- Dolly Parton misses Dollywood event due to 'a few health challenges' after skipping honorary Oscars
- The most effective method to Oversee Unsold SUVs in the Car Business
- Qatar LNG Ships U-Turn After Attempt to Pass Through Hormuz
- Man triggers smoke bomb during failed crypto robbery
- Kaiser Permanente affiliates to pay $556 million to resolve US claims alleging Medicare fraud
- This Week In Space podcast: Episode 187 — An Inspired Enterprise
- NASA’s history-making moon mission aims to send the first woman and person of color to deep space
- Corcept Therapeutics shares surge as lead drug gets FDA nod for ovarian cancer
